EMIROGLU, NAZANCENGIZ, F. P.OZKAYA, D. BiyikBAHALI, A. GulselSu, O.ONSUN, NAHİDE2019-10-052019-10-052016-08-01CENGIZ F. P. , EMIROGLU N., OZKAYA D. B. , BAHALI A. G. , Su O., ONSUN N., -Frequency and risk factors for secondary malignancies in patients with mycosis fungoides-, MELANOMA RESEARCH, cilt.26, 2016https://hdl.handle.net/20.500.12645/6616Mycosis fungoides (MF), the most common form of cutaneous T-cell lymphoma (CTCL), has an incidence of 6.4 per million people [1]. Patients with CTCL have an increased risk of the development of secondary malignancies, particularly lymphomas [2,3]. We conducted a 20-year population-based cohort study to assess the risk factors of secondary cancers in MF patients from our center.eninfo:eu-repo/semantics/openAccessArticle28832009